Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Compston

Showing results (151-160 of 243) with videos related to

Pageof 25
Sort By:
Lancet (London, England)|December 5, 1981
Optic neuritis and multiple sclerosis: do factor B alleles influence progression of disease?A H Fielder, J R Batchelor, B N Vakarelis, et al.
American Journal of Physiology. Renal Physiology|January 23, 2009
Oncostatin M pathway plays a major role in the renal acute phase responseValerie A Luyckx, Lucas V Cairo, Catharine A Compston, et al.
Brain : a Journal of Neurology|August 1, 1989
The role of complement in the pathogenesis of experimental allergic encephalomyelitisC Linington, B P Morgan, N J Scolding, et al.
Journal of Neuroimmunology|May 1, 1989
Myelin-oligodendrocyte glycoprotein (MOG) is a surface marker of oligodendrocyte maturationN J Scolding, S Frith, C Linington, et al.
Neuropathology and Applied Neurobiology|June 1, 1996
Failure to achieve remyelination of demyelinated rat axons following transplantation of glial cells obtained from the adult human brainM P Targett, J Sussman, N Scolding, et al.
Journal of the Neurological Sciences|June 1, 1994
No linkage between multiple sclerosis and the T cell receptor alpha chain locusM Eoli, N W Wood, H F Kellar-Wood, et al.
Journal of Neuroimmunology|March 14, 2000
Interleukin 1 receptor antagonist (IL-1ra) in multiple sclerosisR Feakes, S Sawcer, S Broadley, et al.
Journal of the Neurological Sciences|February 1, 1989
Normal rat serum cytotoxicity against syngeneic oligodendrocytes. Complement activation and attack in the absence of anti-myelin antibodiesN J Scolding, B P Morgan, A Houston, et al.
Annals of Neurology|December 16, 1998
Susceptibility to multiple sclerosis and the immunoglobulin heavy chain gene clusterR Feakes, J Chataway, S Sawcer, et al.
Genetic Epidemiology|January 1, 1997
Empirical genomewide significance levels established by whole genome simulationsS Sawcer, H B Jones, D Judge, et al.
Pageof 25

Showing results (151-160 of 243) with videos related to

Sort By:
Pageof 25
Lancet (London, England)|December 5, 1981
Optic neuritis and multiple sclerosis: do factor B alleles influence progression of disease?A H Fielder, J R Batchelor, B N Vakarelis, et al.
American Journal of Physiology. Renal Physiology|January 23, 2009
Oncostatin M pathway plays a major role in the renal acute phase responseValerie A Luyckx, Lucas V Cairo, Catharine A Compston, et al.
Brain : a Journal of Neurology|August 1, 1989
The role of complement in the pathogenesis of experimental allergic encephalomyelitisC Linington, B P Morgan, N J Scolding, et al.
Journal of Neuroimmunology|May 1, 1989
Myelin-oligodendrocyte glycoprotein (MOG) is a surface marker of oligodendrocyte maturationN J Scolding, S Frith, C Linington, et al.
Neuropathology and Applied Neurobiology|June 1, 1996
Failure to achieve remyelination of demyelinated rat axons following transplantation of glial cells obtained from the adult human brainM P Targett, J Sussman, N Scolding, et al.
Journal of the Neurological Sciences|June 1, 1994
No linkage between multiple sclerosis and the T cell receptor alpha chain locusM Eoli, N W Wood, H F Kellar-Wood, et al.
Journal of Neuroimmunology|March 14, 2000
Interleukin 1 receptor antagonist (IL-1ra) in multiple sclerosisR Feakes, S Sawcer, S Broadley, et al.
Journal of the Neurological Sciences|February 1, 1989
Normal rat serum cytotoxicity against syngeneic oligodendrocytes. Complement activation and attack in the absence of anti-myelin antibodiesN J Scolding, B P Morgan, A Houston, et al.
Annals of Neurology|December 16, 1998
Susceptibility to multiple sclerosis and the immunoglobulin heavy chain gene clusterR Feakes, J Chataway, S Sawcer, et al.
Genetic Epidemiology|January 1, 1997
Empirical genomewide significance levels established by whole genome simulationsS Sawcer, H B Jones, D Judge, et al.
Pageof 25